<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: The aim of this study was to investigate the effects of paxillin on proliferation, migration, invasion, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of HCT-8 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>METHODOLOGY: siRNA plasmids, overexpression <z:mp ids='MP_0002169'>wild-type</z:mp> plasmids and overexpression mutant plasmids were generated and transfected into HCT-8 cells </plain></SENT>
<SENT sid="2" pm="."><plain>The expression of paxillin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein was analyzed, and cell proliferation and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> were measured </plain></SENT>
<SENT sid="3" pm="."><plain>Flow cytometry was used for cell sorting and detection of cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>The invasive ability of HCT-8 cells was also observed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The proliferation, migration and invasive capacity of the HCT-8 cells transfected with siRNA paxillin plasmids were inhibited </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpression of <z:mp ids='MP_0002169'>wild-type</z:mp> paxillin plasmids promoted cell proliferation and also enhanced migration, invasive capacity and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Overexpression of mutant paxillin plasmids inactivated the function of phosphorylation, inhibited cell migration and invasion capacity, but cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and proliferation had no significant difference compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> group </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These findings suggest that paxillin may play an essential role in the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and RNAi targeting of paxillin may be a potential therapeutic strategy for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>